Investors

Development of biomedical products: vaccines, antibodies, gene therapy drugs, etc.

Development and implementation into clinical practice of medical devices based on gene-activated materials of regenerative medicine and test systems for medical genetics.

Biobanking, genetic research for medical and scientific applications. Regenerative medicine services based on cell technologies.

A business model in the biotech sector has unique features that differentiate it from the general market. This is reflected in the specific approach and particular methods of evaluating biotech assets for investment purposes.

Information about the company's financial and operational activities.

The issuer's reports on securities (quarterly and annual), list of affiliates (quarterly), changes in the list of affiliates and notifications of facts and information (if any) in accordance with the requirements of the Russian legislation.